0001600620-24-000036.txt : 20240307
0001600620-24-000036.hdr.sgml : 20240307
20240307164347
ACCESSION NUMBER: 0001600620-24-000036
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240306
FILED AS OF DATE: 20240307
DATE AS OF CHANGE: 20240307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Donley Matthew Maxwell
CENTRAL INDEX KEY: 0001636642
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36421
FILM NUMBER: 24730834
MAIL ADDRESS:
STREET 1: 4520 EAST WEST HIGHWAY, 3RD FLOOR
CITY: BETHESDA
STATE: MD
ZIP: 20814
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aurinia Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001600620
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 981231763
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: #140, 14315 - 118 AVENUE
CITY: EDMONTON
STATE: A0
ZIP: T5L 4S6
BUSINESS PHONE: 250-744-2487
MAIL ADDRESS:
STREET 1: #140, 14315 - 118 AVENUE
CITY: EDMONTON
STATE: A0
ZIP: T5L 4S6
4
1
wk-form4_1709847815.xml
FORM 4
X0508
4
2024-03-06
0
0001600620
Aurinia Pharmaceuticals Inc.
AUPH
0001636642
Donley Matthew Maxwell
#140, 14315-118 AVENUE
EDMONTON
A0
T5L 4S6
ALBERTA, CANADA
0
1
0
0
EVP, Ops & Strategy
0
Common Stock
2024-03-06
4
S
0
40665
5.51
D
584072
D
Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units related to the March 2, 2022 and March 2, 2023 grants.
The price in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.475 to $5.755, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
/s/ Matthew Maxwell Donley
2024-03-07